首页|联合检测血清和胸水中多项肿瘤标志物对良恶性胸腔积液的鉴别诊断价值

联合检测血清和胸水中多项肿瘤标志物对良恶性胸腔积液的鉴别诊断价值

扫码查看
目的探讨联合检测血清和胸水中癌胚抗原(CEA)、神经元特异性烯醇化酶(NSE)、细胞角质蛋白19片断(CYFRA21-1)对良恶性胸腔积液的鉴别诊断价值.方法96例临床已确诊的胸腔积液患者(恶性组50例,良性组46例)采用全自动免疫分析系统进行CEA、NSE、CYFRA21-1含量测定.结果恶性胸腔积液患者的3种肿瘤标志物水平均明显高于良性疾病组,差异有统计学意义(P <0.05).联合检测血清及胸腔积液3项指标,恶性胸腔积液诊断的敏感性为98%,特异性为80%,准确性为89%,较检测单一指标提高了诊断的敏感度、准确度.结论联合检测胸腔积液中CEA、NSE、CYFRA21-1对良恶性胸腔积液的鉴别诊断有重要价值,能提高诊断准确率.
Differential diagnostic value of joint determination of multiple indices in serum and pleural effusion between benign and malignant pleural exudates
Objective To discuss detection of CEA,NSE and CYFRA21-1 in serum and pleural fluid for differentiation of benign from malignant pleural fluid diagnosis value. Methods Determination of content of CEA, NSE, CYFRA21-1 by using electrochemiluminescence immunoassay kit in 96 cases of patients with pleural fluid(the malignant group 50 cases, the benign group 46 cases). Results Levels of 3 tumor markers of patients with malignant pleural effusions were significantly higher than those of patients with benign ones(P <0.05). Detection of serum and pleural effusion in 3 indicators, the sensitivity of diagnosis for malignant pleural effusion was 98%, the specificity was 80%, the accuracy was 89%. Improves diagnostic sensitivity, accuracy than detection of single index. Conclusion Combined detection of pleural effusion in CEA, NSE, CYFRA21-1 in he differential diagnosis of benign from malignant pleural effusions have important value, improve the accuracy of diagnosis.

CEANSECYFRA21-1Benign malignant pleural fluidDifferential diagnosis

刘长波、李丽、杨利、孙启玉

展开 >

163001 大庆油田总医院呼吸内科

癌胚抗原 神经元特异性烯醇化酶 细胞角质蛋白19片断 良恶性胸腔积液 鉴别诊断

2013

中国医疗前沿
中国医院协会

中国医疗前沿

影响因子:0.186
ISSN:1673-5552
年,卷(期):2013.(1)
  • 1
  • 2